Fully covered self-expanding metal stents (FC-SEMSs), which can be removed from the
bile duct, have recently been used in the main pancreatic duct (MPD) in chronic pancreatitis.
The aim of this study was to investigate the feasibility, safety, and efficacy of
FC-SEMSs in painful chronic pancreatitis with refractory pancreatic strictures. The
primary endpoints were technical success and procedure-related morbidity. Secondary
endpoints were pain relief at the end of follow-up and resolution of the dominant
pancreatic stricture at endoscopic retrograde pancreatography. Over 5 months, 10 patients
with painful chronic pancreatitis and refractory dominant pancreatic duct strictures
were treated with FC-SEMSs. All FC-SEMSs were successfully released and removed, although
two stents were embedded in the MPD at their distal end and treated endoscopically
without complications. Mild abdominal pain was noted in three patients after stent
release. During treatment, pain relief was achieved in nine patients, but one continued
to take morphine, because of addiction. Cholestasis developed in two patients and
was treated endoscopically; no patient developed acute pancreatitis or pancreatic
sepsis. After stent removal, the diameter of the narrowest MPD stricture had increased
significantly from 3.5 mm to 5.8 mm. Patients were followed up for a mean of 19.8
months: two patients who continued drinking alcohol presented with mild acute pancreatitis;
one patient developed further chronic pancreatic pain; and one had a transient pain
episode. At the end of the study, nine patients no longer had chronic pain and no
patients had required surgery. Endoscopic treatment of refractory MPD stricture in
chronic pancreatitis by placement of an FC-SEMS appears feasible, safe, and potentially
effective.